Joe Raedle/Getty Images

The FDA is warning patients, caregivers and health care professional about potential safety issues with the EpiPen as well as generic epinephrine auto-injectors. Pfizer and Mylan said the device could fail or activate prematurely if a blue safety release is removed with sideways force rather than with two hands, as recommended.

Related Summaries